Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
17.59
+0.17 (0.98%)
At close: Jan 21, 2026, 4:00 PM EST
17.45
-0.14 (-0.80%)
After-hours: Jan 21, 2026, 5:04 PM EST
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $546.46 million as of January 21, 2026. Its market cap has increased by 362.59% in one year.
Market Cap
546.46M
Enterprise Value
422.08M
1-Year Change
362.59%
Ranking
Category
Stock Price
$17.59
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $546.46M, an increase of 3.36%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 541.18M | -2.13% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 575.31M |
| Keros Therapeutics | 566.36M |
| Replimune Group | 556.95M |
| LB Pharmaceuticals | 554.30M |
| Forte Biosciences | 551.88M |
| Alpha Tau Medical | 549.95M |
| Design Therapeutics | 537.17M |
| CorMedix | 533.40M |